TRIM59 and graft versus host disease: Further analysis of these DEGs showed that Eph receptor B2 (EphB2), involved in the inhibition of T cell activity, SRY-box transcription factor 11 (SOX11), and tripartite motif containing 59 (TRIM59), which promotes MSC differentiation, were associated with the outcomes of GVHD treated by MSCs.